article thumbnail

Logistics in Focus: Orchestrating the Challenges of Cell Therapy

Worldwide Clinical Trials

While clinical supply is essential to any successful trial, autologous cell therapy trials occupy the far end of the spectrum regarding risk tolerance. The process, from patient coordination through manufacturing and administration, is intricate, time-sensitive, and highly regulated.

article thumbnail

Altasciences' comprehensive, integrated solution for clinical supply manufacture

Bio Pharma Dive

Integrated CRO/CDMO solutions for accelerated and more efficient early drug development programs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Nearly every biopharma with a portfolio of drugs in development spanning traditional small molecules and biologics and the newer CGT operates with separate clinical supply organizations per these therapy areas. This is due to major differences throughout the clinical supply chain in both requirements and management practices.

article thumbnail

NUCLIDIUM and PharmaLogic partner to develop copper-based theranostics in US

Pharmaceutical Technology

NUCLIDIUM has signed a strategic collaboration deal with PharmaLogic for the manufacturing and clinical supply of copper-based theranostics ⁶¹Cu in the US. ⁶¹Cu It will also enable NUCLIDIUM to achieve a sustainable supply of ⁶¹Cu in the US for its proposed clinical trials and upcoming commercialised products.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.

article thumbnail

ASLAN Pharmaceuticals and Thermo Fisher Scientific partner on eblasakimab manufacturing

BioPharma Reporter

Thermo Fisher Scientific will provide biologic manufacturing capabilities and scale-up capacity to manage clinical supply of eblasakimabÂfor future Phase 3 studies.

article thumbnail

IN FOCUS: Syngene International

Pharmaceutical Technology

The company undertook several initiatives recently to expand its business through new partnerships, expansion of existing relationships, and investment in manufacturing capacity. Initially centered on Librela®, this agreement paves the way for developing and manufacturing other molecules in the coming years. until 2026.